Murata, Ayato
Angata, Kiyohiko
Sogabe, Maki
Sato, Shunsuke
Ichida, Takafumi
Narimatsu, Hisashi
Genda, Takuya
Article History
Received: 1 March 2022
Accepted: 25 May 2022
First Online: 31 May 2022
Declarations
:
: The study was approved by the Ethics Committee of Juntendo University Shizuoka Hospital (No. 633, February 5th, 2019) and was performed in accordance with the Declaration of Helsinki (as revised in Brazil 2013). Informed consent was obtained in the form of opt-out on the website.
: Not applicable.
: TG has received honoraria from AbbVie, Gilead Sciences Inc., and MSD K.K., and research funding from AbbVie, Otsuka Pharmaceutical, Mitsubishi Tanabe Pharma, JIMRO, and Takeda Pharmaceutical. KA, MS, and HN are employees and CEO of RCMG, Inc., one of the AIST venture companies. AM, SS, and TI had no competing interests.